Phosphoinositide 3-kinase in Health and Disease Volume 2 /
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
Edición: | 1st ed. 2011. |
Colección: | Current Topics in Microbiology and Immunology,
347 |
Temas: | |
Acceso en línea: | Texto Completo |
Sumario: | From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here. |
---|---|
Descripción Física: | X, 306 p. 79 illus., 46 illus. in color. online resource. |
ISBN: | 9783642148163 |
ISSN: | 2196-9965 ; |